Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test
- PMID: 20205282
- PMCID: PMC2835788
- DOI: 10.3748/wjg.v16.i9.1110
Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test
Abstract
Aim: To examine the feasibility of predicting the flare-up of ulcerative colitis (UC) before symptoms emerge using the immunochemical fecal occult blood test (I-FOBT).
Methods: We prospectively measured fecal hemoglobin concentrations in 78 UC patients using the I-FOBT every 1 or 2 mo.
Results: During a 20 mo-period, 823 fecal samples from 78 patients were submitted. The median concentration of fecal hemoglobin was 41 ng/mL (range: 0-392 500 ng/mL). There were three types of patients with regard to the correlation between I-FOBT and patient symptoms; the synchronous transition type with symptoms (44 patients), the unrelated type with symptoms (19 patients), and the flare-up predictive type (15 patients). In patients with the flare-up predictive type, the values of I-FOBT were generally low during the study period with stable symptoms. Two to four weeks before the flare-up of symptoms, the I-FOBT values were high. Thus, in these patients, I-FOBT could predict the flare-up before symptoms emerged.
Conclusion: Flare-up could be predicted by I-FOBT in approximately 20% of UC patients. These results warrant periodical I-FOBT in UC patients.
Figures

Similar articles
-
Assessment of disease activity by fecal immunochemical test in ulcerative colitis.World J Gastroenterol. 2016 Dec 28;22(48):10617-10624. doi: 10.3748/wjg.v22.i48.10617. World J Gastroenterol. 2016. PMID: 28082814 Free PMC article.
-
Consecutive Measurements by Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Detect Clinical Relapse.J Crohns Colitis. 2016 Jun;10(6):687-94. doi: 10.1093/ecco-jcc/jjw025. Epub 2016 Jan 22. J Crohns Colitis. 2016. PMID: 26802083
-
Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.Am J Gastroenterol. 2015 Jun;110(6):873-80. doi: 10.1038/ajg.2015.66. Epub 2015 Mar 31. Am J Gastroenterol. 2015. PMID: 25823769
-
Fecal immunochemical test for predicting mucosal healing in ulcerative colitis patients: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2018 May;33(5):990-997. doi: 10.1111/jgh.14121. Epub 2018 Mar 13. J Gastroenterol Hepatol. 2018. PMID: 29427297
-
[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.
Cited by
-
Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.World J Gastroenterol. 2016 Jun 7;22(21):5079-87. doi: 10.3748/wjg.v22.i21.5079. World J Gastroenterol. 2016. PMID: 27275100 Free PMC article.
-
Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction: A Nationwide Population Study.J Am Heart Assoc. 2021 Jan 5;10(1):e017783. doi: 10.1161/JAHA.120.017783. Epub 2020 Dec 29. J Am Heart Assoc. 2021. PMID: 33372535 Free PMC article.
-
Patient self-reported symptoms using visual analog scales are useful to estimate endoscopic activity in ulcerative colitis.Intest Res. 2018 Oct;16(4):579-587. doi: 10.5217/ir.2018.00021. Epub 2018 Oct 10. Intest Res. 2018. PMID: 30301332 Free PMC article.
-
Assessment of disease activity by fecal immunochemical test in ulcerative colitis.World J Gastroenterol. 2016 Dec 28;22(48):10617-10624. doi: 10.3748/wjg.v22.i48.10617. World J Gastroenterol. 2016. PMID: 28082814 Free PMC article.
-
Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis.Gut Liver. 2022 Sep 15;16(5):736-745. doi: 10.5009/gnl210371. Epub 2022 Feb 11. Gut Liver. 2022. PMID: 35145044 Free PMC article.
References
-
- Allison JE. Review article: faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther. 1998;12:1–10. - PubMed
-
- Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol. 2005;100:1393–1403. - PubMed
-
- Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–1371. - PubMed
-
- Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477. - PubMed
-
- Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical